Literature DB >> 8559960

How many HIV infections are there in Israel? Reconstructing HIV incidence from AIDS case reporting.

E H Kaplan1, P E Slater, V Soskolne.   

Abstract

BACKGROUND: The reporting of AIDS cases to Israel's Ministry of Health is believed to be accurate, but the completeness of HIV surveillance is unknown. We implement a model that reconstructs HIV incidence in Israel from AIDS case reports excluding Ethiopian immigrants.
METHODS: We apply the well-known method of backcalculation to AIDS cases reported to the Ministry of Health. The data are adjusted statistically to account for reporting delays and the elimination of AIDS Related Complex reporting. The analysis also accounts for the impact of differential administration of antiretroviral therapy to HIV-infected persons over time.
RESULTS: Excluding Ethiopian immigrants, we find that the cumulative number of HIV infections reported to the Ministry of Health through December 1993 (1,011) is not statistically different from the model's estimate of 922 (z = 1.04; p = 0.30), though the reported number of new infections in recent years exceeds the modeleted rate.
CONCLUSIONS: The low HIV incidence estimated among non-Ethiopian Israelis is consistent with other studies of sexually transmitted diseases and HIV-related risky behavior in Israel. This result counters the hypothesis that an explosive HIV epidemic will occur. That the number of recently reported new infections exceeds the estimate from the model could indicate that the reporting system is catching up with the extant spread of disease, or that the model is missing some aspect of the dynamics of HIV in Israel. We suggest that comparing future annual HIV incidence rates to the model's upper bound of 80 infections per year will enable resolution of this issue over time.

Entities:  

Mesh:

Year:  1995        PMID: 8559960

Source DB:  PubMed          Journal:  Public Health Rev        ISSN: 0301-0422


  1 in total

1.  Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.

Authors:  Boaz Avidor; Dan Turner; Zohar Mor; Shirley Chalom; Klaris Riesenberg; Eduardo Shahar; Shimon Pollack; Daniel Elbirt; Zev Sthoeger; Shlomo Maayan; Karen Olshtain-Pops; Diana Averbuch; Michal Chowers; Valery Istomin; Emilia Anis; Ella Mendelson; Daniela Ram; Itzchak Levy; Zehava Grossman
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.